An initial, straight-forward explanation that oncogenic and tumor progression supporting EpCAM activities rest on interfering with E-cadherin-mediated adhesion required revisiting, when it was realized that EpCAM can be cleaved by TACE and subsequently presenilin1, which generates EpICD (396). This evidence concerns the gene EPCAM and neoplasm.